Skip to content
value.today

Neptune Technologies & Bioressources Inc.

Total raised
$45 M
3 rounds on record
Latest round
$4 M
Jul 2022
First round on record
May 2011
Today
Private
No later event on record

Funding rounds

3 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Neptune Technologies & Bioressources Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2022$4 MNo. 3$2 to $10 million

Neptune Technologies & Bioressources Inc.: Raise no. 3, Jul 2022

Investors in this round

1 investor had bought by the notice of Jul 27, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: The securities were issued as consideration for a $3,000,000 convertible loan.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Quebec, Canada

People named in the notice

  • Emily Fletty · Executive Officer
  • Jessica Adkins · Executive Officer
  • John Wirt · Executive Officer
  • Michael Cammarata · Executive Officer, Director
  • Morry Brown · Executive Officer
  • Raymond Silcock · Executive Officer
  • Joseph Buaron · Director
  • Julie Phillips · Director
  • Michael De Geus · Director
  • Philip Sanford · Director
  • Ronald Denis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”

Signed by John S. Wirt, General Counsel and Corporate Secretary. Newest notice filed Jul 27, 2022. Read the notice at the SEC.

equitySEC
Feb 2021$12 MIssued in a merger or acquisition$10 to $50 million

Neptune Technologies & Bioressources Inc.: Private sale, Feb 2021

Investors in this round

8 investors had bought by the notice of Feb 22, 2021: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Quebec, Canada

People named in the notice

  • Michael Cammarata · Executive Officer, Director
  • Toni Rinow · Executive Officer
  • Francis F. Rochon · Director
  • Jane Pemberton · Director
  • John Moretz · Director
  • Joseph Buaron · Director
  • Michael A. De Geus · Director
  • Richard F. Schottenfeld · Director
  • Ronald Denis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Toni Rinow, Chief Financial Officer and Global Operating Officer. Newest notice filed Feb 22, 2021. Read the notice at the SEC.

equitySEC
Oct 2020$35 MNo. 2$10 to $50 million

Neptune Technologies & Bioressources Inc.: Raise no. 2, Oct 2020

Investors in this round

11 investors had bought by the notice of Nov 5, 2020: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $59 M offered; $24 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$1,363,600
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Quebec, Canada

People named in the notice

  • Michael Cammarata · Executive Officer, Director
  • Toni Rinow · Executive Officer
  • Francis F. Rochon · Director
  • Jane Pemberton · Director
  • John Moretz · Director
  • Joseph Buaron · Director
  • Michael A. De Geus · Director
  • Richard F. Schottenfeld · Director
  • Ronald Denis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • A.G.P./Alliance Global Partners (CRD 8361) · New York, New YorkSold in CA, DC, MN, NY

Remarks in the notice

  • On the amounts: “The Issuer may receive up to an additional $23,697,902 if and when purchasers exercise the Warrants issued pursuant to this offering.”

Signed by Toni Rinow, Chief Financial Officer and Global Operating Officer. Newest notice filed Nov 5, 2020. Read the notice at the SEC.

equity, optionsSEC
Jul 2019$37 MIssued in a merger or acquisition$10 to $50 million

Neptune Technologies & Bioressources Inc.: Private sale, Jul 2019

Investors in this round

12 investors had bought by the notice of Jul 25, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Quebec, Canada

People named in the notice

  • Mario F. Paradis · Executive Officer
  • Michael Cammarata · Executive Officer
  • Helene F. Fortin · Director
  • John Moretz · Director
  • Katherine Crewe · Director
  • Rick F. Schottenfeld · Director
  • Ronald F. Denis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company, LLC (CRD 7616) · New York, New YorkSold in CA, CT, FL, NC, NY

Remarks in the notice

  • On a merger: “The Company conducted this offering in order to finance their acquisition of SugarLeaf Labs LLC and Forest Remedies LLC.”

Signed by Michael Cammarata, Chief Executive Officer. Newest notice filed Jul 25, 2019. Read the notice at the SEC.

equitySEC
May 2011$6 MNo. 1$2 to $10 million

Neptune Technologies & Bioressources Inc.: Raise no. 1, May 2011

Investors in this round

8 investors had bought by the notice of May 17, 2011: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: The securities offered are units, each consisting of one common share and one quarter (1/4) of one common share purchase warrant.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$367,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Quebec, Canada

People named in the notice

  • Andre Godin · Executive Officer · Vice President Administration and Finance
  • Henri Harland · Director, Executive Officer · Director, President and Chief Executive Officer
  • Tina Sampalis · Executive Officer · Chief Scientific Officer
  • Daniel Perry · Director
  • Jean-Claude Debard · Director
  • Michel Chartrand · Director
  • Ronald Denis · Director · Director and Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ROTH Capital Partners (CRD 15407) · Newport Beach, CaliforniaSold in IL, MA, NY, PA

Signed by Andre Godin, Vice President Administration and Finance. Newest notice filed May 17, 2011. Read the notice at the SEC.

equity, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Neptune Technologies & Bioressources Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2022).

    SEC Form D · Jul 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Neptune Technologies & Bioressources Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Neptune Technologies & Bioressources Inc.
NameRoleNamed in
Emily FlettyExecutive officerJul 2022
Jessica AdkinsExecutive officerJul 2022
John WirtExecutive officerJul 2022
Michael CammarataExecutive officerJul 2022
Morry BrownExecutive officerJul 2022
Raymond SilcockExecutive officerJul 2022
Toni RinowExecutive officerFeb 2021
Mario F. ParadisExecutive officerJul 2019
Andre GodinVice President Administration and FinanceMay 2011
Henri HarlandDirector, President and Chief Executive OfficerMay 2011
Tina SampalisChief Scientific OfficerMay 2011
Joseph BuaronDirectorJul 2022
Julie PhillipsDirectorJul 2022
Michael CammarataDirectorJul 2022
Michael De GeusDirectorJul 2022
Philip SanfordDirectorJul 2022
Ronald DenisDirectorJul 2022
Francis F. RochonDirectorFeb 2021
Jane PembertonDirectorFeb 2021
John MoretzDirectorFeb 2021
Michael A. De GeusDirectorFeb 2021
Richard F. SchottenfeldDirectorFeb 2021
Helene F. FortinDirectorJul 2019
Katherine CreweDirectorJul 2019
Rick F. SchottenfeldDirectorJul 2019
Ronald F. DenisDirectorJul 2019
Daniel PerryDirectorMay 2011
Henri HarlandDirector, President and Chief Executive OfficerMay 2011
Jean-Claude DebardDirectorMay 2011
Michel ChartrandDirectorMay 2011